EP GLOBAL OPPORTUNITIES TRUST PLC
PORTFOLIO HOLDINGS AS AT 31 AUGUST 2019
Rank | Company | Sector | Country | % of Net assets |
|
1 | Roche * | Health Care | Switzerland | 3.5 | |
2 | Novartis | Health Care | Switzerland | 3.3 | |
3 | Vodafone | Telecommunications | United Kingdom | 3.2 | |
4 | AstraZeneca | Health Care | United Kingdom | 3.1 | |
5 | Verizon | Telecommunications | United States | 3.0 | |
6 | Sanofi | Health Care | France | 2.7 | |
7 | Orange | Telecommunications | France | 2.7 | |
8 | Singapore Telecommunications | Telecommunications | Singapore | 2.7 | |
9 | East Japan Railway | Industrials | Japan | 2.7 | |
10 | Royal Dutch Shell A | Oil & Gas | Netherlands | 2.6 | |
11 | Sony | Consumer Goods | Japan | 2.5 | |
12 | Tesco | Consumer Services | United Kingdom | 2.5 | |
13 | Sumitomo Mitsui Financial | Financials | Japan | 2.4 | |
14 | Galaxy Entertainment | Consumer Services | Hong Kong | 2.4 | |
15 | Swire Pacific A | Industrials | Hong Kong | 2.4 | |
16 | Edinburgh Partners Emerging Opportunities Fund | Financials | Other | 2.4 | |
17 | China Mobile | Telecommunications | China | 2.4 | |
18 | Total | Oil & Gas | France | 2.4 | |
19 | ENI | Oil & Gas | Italy | 2.4 | |
20 | Sumitomo Mitsui Trust | Financials | Japan | 2.3 | |
21 | BP | Oil & Gas | United Kingdom | 2.3 | |
22 | Nokia | Technology | Finland | 2.3 | |
23 | Bangkok Bank ** | Financials | Thailand | 2.2 | |
24 | ING | Financials | Netherlands | 2.2 | |
25 | Samsung SDI | Industrials | South Korea | 2.2 | |
26 | BNP Paribas | Financials | France | 2.1 | |
27 | Bayer | Health Care | Germany | 2.1 | |
28 | Comsys | Industrials | Japan | 2.1 | |
29 | Commerzbank | Financials | Germany | 2.0 | |
30 | Shanghai Fosun Pharmaceutical H | Health Care | China | 1.9 | |
31 | Panasonic | Consumer Goods | Japan | 1.9 | |
32 | Apache | Oil & Gas | United States | 1.8 | |
33 | Telefonica | Telecommunications | Spain | 1.8 | |
34 | Japan Tobacco | Consumer Goods | Japan | 1.8 | |
35 | BBVA | Financials | Spain | 1.7 | |
36 | CK Hutchison | Industrials | Hong Kong | 1.6 | |
37 | Astellas Pharma | Health Care | Japan | 1.2 | |
38 | Fresenius Medical Care | Health Care | Germany | 1.2 | |
39 | Kirin | Consumer Goods | Japan | 0.8 | |
40 | Rohm | Technology | Japan | 0.5 | |
Total equity investments | 89.3 | ||||
Cash and other net assets | 10.7 | ||||
Net assets | 100.0 | ||||
* The investment is in non-voting shares **The investment is in non-voting depositary receipts |
|||||
GEOGRAPHICAL DISTRIBUTION
31 August 2019 | % of Net Assets |
Europe | 35.0 |
Japan | 18.2 |
Asia Pacific | 17.8 |
United Kingdom | 11.1 |
United States | 4.8 |
Other | 2.4 |
Cash and other net assets | 10.7 |
100.0 |
SECTOR DISTRIBUTION
31 August 2019 | % of Net Assets |
Health Care | 19.0 |
Financials | 17.3 |
Telecommunications | 15.8 |
Oil & Gas | 11.5 |
Industrials | 11.0 |
Consumer Goods | 7.0 |
Consumer Services | 4.9 |
Technology | 2.8 |
Cash and other net assets | 10.7 |
100.0 |
As at 31 August 2019, the net assets of the Company were £133,473,000.
16 September 2019
Legal Entity Identifier: 2138005T5CT5ITZ7ZX58
Enquiries:
Kenneth Greig
Edinburgh Partners AIFM Limited
Tel: 0131 270 3800
The Company’s registered office address is:
27-31 Melville Street
Edinburgh
EH3 7JF